Search Results 1591-1600 of 3937 for Solid
Has measurable disease according to Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST v1.1), defined as at least 1 lesion that can be ...
PTT-936, an Alpha Kinase 1 (ALPK1) Activator, Alone or in Combination with Anti-PD-1/L1 in Patients with Locally Advanced or Metastatic Solid Tumors.
* Prior allogeneic stem cell or solid organ transplantation. * Treatment with a live, attenuated vaccine within 4 weeks prior to initiation of study ...
... Solid Tumors version 1.1 (RECIST 1.1) after initial treatment. Safety and Durability of Sirolimus for Treatment of LAM. Rochester, Minn., Jacksonville, Fla ...
... Solid Tumors version 1.1 (RECIST 1.1) after initial treatment. Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With ...
Many newborns have slightly uneven heads. But is it cause for worry? Understand what causes unevenness in babies' heads and when treatment is needed. What ...
Prior allogeneic stem cell transplant or solid organ transplant. Active hepatitis B, active hepatitis C, or positive for human immunodeficiency virus (HIV) ...
Measurable disease per modified Response Evaluation Criteria in Solid Tumors (RECIST) criteria for mesothelioma; Eastern Cooperative Oncology Group (ECOG) ...
Calcium hydroxylapatite (Radiesse). This filler is used to contour the jaw line, restore volume in the cheeks, and treat deeper wrinkles and skin folds. Calcium ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.